ASH hears you!
This page contains guidance from ASH President Stephanie Lee, MD, MPH, for hematology researchers in navigating the COVID-19 public health crisis. For additional resources, please visit hematology.org/covid-19.
Thanks so much to everyone who has accessed the ASH website and provided questions, comments and suggestions. We will be making updates daily. I will use this blog to highlight new material on the website and share what ASH is doing.
First, a few housekeeping items. If you see something that is really useful, or conversely, if ASH starts working on something that you know is already been done by someone else, please let us know. We want to concentrate our efforts on filling gaps. Second, think twice before you “reply all.” Everyone is getting inundated with emails. Third, watch out for computer viruses. They are circulating too. Most importantly, please take care of yourselves and each other.
Here’s what we heard would be helpful and what we are working on:
- Guidance on clinical trials issues – outline problems and what solutions are necessary, drug distribution, unblinding, necessity of routine checks, enrollment holds, continuing pts on study, monitoring visits
- Clinical guidance from China: V7 guidelines from China and the COVID-19 Handbook
- Guidance on telemedicine: see some information on coa.org.
- Transplant decisions/delays
- Support to help maintain the blood supply: see Transfusion support guidelines under AABB.
- Palliative care toolkit for difficult conversations
- Compendium scientific and educational webinar content for those at home
- Compendium of clinical trials
- Annotated important literature
- Guidance on reimbursement issues, including international
